A detailed history of Aspen Investment Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Aspen Investment Management Inc holds 5,537 shares of AMGN stock, worth $1.75 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
5,537
Previous 5,561 0.43%
Holding current value
$1.75 Million
Previous $1.58 Million 9.42%
% of portfolio
0.86%
Previous 0.8%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$262.75 - $319.31 $6,306 - $7,663
-24 Reduced 0.43%
5,537 $1.73 Million
Q1 2024

Apr 26, 2024

SELL
$268.87 - $324.56 $9,141 - $11,035
-34 Reduced 0.61%
5,561 $1.58 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $3,835 - $4,326
-15 Reduced 0.27%
5,595 $1.61 Million
Q3 2023

Nov 01, 2023

SELL
$218.65 - $271.46 $26,675 - $33,118
-122 Reduced 2.13%
5,610 $1.51 Million
Q2 2023

Jul 28, 2023

SELL
$214.27 - $253.37 $23,998 - $28,377
-112 Reduced 1.92%
5,732 $1.27 Million
Q1 2023

May 16, 2023

SELL
$225.79 - $275.2 $14,676 - $17,888
-65 Reduced 1.1%
5,844 $1.41 Million
Q4 2022

Feb 06, 2023

SELL
$229.03 - $291.01 $68,250 - $86,720
-298 Reduced 4.8%
5,909 $1.55 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $5,835 - $6,581
26 Added 0.42%
6,207 $1.4 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $3,460 - $3,851
-15 Reduced 0.24%
6,181 $1.5 Million
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $19,295 - $21,346
-88 Reduced 1.4%
6,196 $1.5 Million
Q4 2021

Jan 26, 2022

SELL
$198.88 - $227.6 $175,014 - $200,288
-880 Reduced 12.28%
6,284 $1.41 Million
Q3 2021

Dec 06, 2021

SELL
$212.27 - $248.7 $88,516 - $103,707
-417 Reduced 5.5%
7,164 $1.52 Million
Q2 2021

Aug 04, 2021

BUY
$233.58 - $259.14 $28,029 - $31,096
120 Added 1.61%
7,581 $1.85 Million
Q1 2021

Jun 10, 2021

SELL
$221.91 - $258.6 $1,109 - $1,293
-5 Reduced 0.07%
7,461 $1.86 Million
Q4 2020

Jan 25, 2021

BUY
$216.38 - $257.67 $12,982 - $15,460
60 Added 0.81%
7,466 $1.72 Million
Q3 2020

Nov 30, 2020

BUY
$234.65 - $260.95 $31,208 - $34,706
133 Added 1.83%
7,406 $1.88 Million
Q2 2020

Aug 06, 2020

BUY
$197.81 - $242.74 $117,301 - $143,944
593 Added 8.88%
7,273 $1.72 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $71,984 - $95,471
-395 Reduced 5.58%
6,680 $1.35 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $10,406 - $13,376
55 Added 0.78%
7,075 $1.71 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $27,857 - $33,379
-160 Reduced 2.23%
7,020 $1.36 Million
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $12,970 - $14,622
70 Added 0.98%
7,180 $1.49 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $7,472 - $8,392
-45 Reduced 0.63%
7,110 $1.31 Million
Q3 2017

Nov 15, 2017

BUY
$167.29 - $191.0 $1.2 Million - $1.37 Million
7,155
7,155 $1.33 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aspen Investment Management Inc Portfolio

Follow Aspen Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspen Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Aspen Investment Management Inc with notifications on news.